期刊文献+

卵巢上皮性癌组织中IGF-1、E-cad蛋白的表达以及IGF-1对卵巢癌SKOV3细胞E-cad表达和侵袭力的影响 被引量:11

Expressions of IGF-1 and E-cad in epithelial ovarian cancer tissue and effect of IGF-1 on E-cad expression and invasion in SKOV3 cell
下载PDF
导出
摘要 目的:检测卵巢上皮性癌组织中胰岛素样生长因子-1(IGF-1)和上皮性钙黏连蛋白(E-cad)的表达以及IGF-1作用于卵巢癌SKOV3细胞后E-cad蛋白的表达和细胞侵袭力的改变,探讨IGF-1在上皮间质转化中的作用。方法:采用免疫组化SP法检测30例卵巢上皮性癌、10例卵巢上皮性交界性肿瘤、10例卵巢良性肿瘤及10例正常卵巢组织中IGF-1及E-cad蛋白的表达。以不同质量浓度(0、25、50、100、200μg/L)的IGF-1刺激SKOV3细胞,应用实时荧光定量PCR法及Western blot法检测E-cad mRNA和蛋白的表达,Transwell法检测细胞侵袭力的变化。结果:卵巢上皮性癌、卵巢上皮性交界性肿瘤、卵巢良性肿瘤及正常卵巢组织中IGF-1的阳性表达率分别为73.3%、30.0%、20.0%和10.0%,E-cad的阳性表达率分别为36.7%、60.0%、70.0%和90.0%;与其他3种组织比较,卵巢上皮性癌组织中IGF-1蛋白的阳性表达率升高,E-cad蛋白的阳性表达率降低(P均<0.05);卵巢上皮性癌组织中IGF-1和E-cad的表达均与临床分期、组织学分级、两级分级系统有关(P均<0.05),而与年龄、组织学类型无关(P均>0.05),且在卵巢上皮性癌组织中IGF-1与E-cad蛋白的表达呈负相关(rP=-0.396,P=0.018)。不同质量浓度的IGF-1作用于SKOV3细胞后,E-cad的表达逐渐降低,SKOV3细胞侵袭力增强,且呈剂量依赖性(P<0.05)。结论:IGF-1、E-cad可能与上皮性卵巢癌的上皮间质转化、侵袭转移有关。 Aim: To detect the expressions of IGF-1 and E-cad in epithelial ovarian cancer tissue and the changes of the expression of E-cad and the cell invasion after SKOV3 cells were dealt with IGF-1,so as to study the role of IGF-1 during epithelial-mesenchymal transition( EMT). Methods: Immunohistochemical SP staining was conducted to detect the expressions of IGF-1 and E-cad in tissue from 30 patients with epithelial ovarian cancer,10 patients with borderline ovarian tumor,10 patients with benign epithelial tumor and 10 controls with normal ovary. SKOV3 cells were treated with different concentrations( 0,25,50,100,200 μg/L) of IGF-1,and the expression of E-cad was observed by real-time reverse transcription-PCR and Western blot,and the invasion was detected by Transwell assay. Results: The positive expression rate of IGF-1 in the epithelial ovarian cancer,borderline ovarian tumor,benign epithelial tumor and normal ovarian tissue was73. 3%,30. 0%,20. 0% and 10. 0%,while that of E-cad in the above tissue was 36. 7%,60. 0%,70. 0% and 90. 0%;compared with the other 3 groups,the positive expression rate of IGF-1 was increased and that of E-cad was decreased in epithelial ovarian cancer tissue( P〈0. 05). The expressions of IGF-1 and E-cad were related with the clinical stage,organization classification and two-tier grading system in epithelial ovarian cancer tissue( P〈0. 05),but not with age or pathological type( P〈0. 05). In the epithelial ovarian cancer tissue,IGF-1 and E-cad had negative correlation( rP=- 0. 396,P =0. 018). The expression of E-cad reduced after SKOV3 cells were dealt with IGF-1( P〈0. 05). IGF-1 promoted invasion of SKOV3 cells in a concentration-dependent manner( P〈0. 05). Conclusion: IGF-1 and E-cad may be concerned with EMT and invasion of epithelial ovarian cancer.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2016年第3期396-401,共6页 Journal of Zhengzhou University(Medical Sciences)
关键词 卵巢肿瘤 胰岛素样生长因子-1 上皮性钙黏连蛋白 侵袭 SKOV3细胞 ovarian neoplasm insulin-like growth factor-1 E-cad invasion SKOV3 cell
  • 相关文献

参考文献17

  • 1JAYSON GC, KOHN EC, KITCHENER HC, et al. Ovarian cancer[ J]. Lancet ,2014,384( 9951 ) : 1376.
  • 2SIEGEL RL, MILLER KD, JEMAL A. Cancer statistics, 2015 [ J ]. CA Cancer J Clin ,2015,65 ( 1 ) :5.
  • 3LAMOUILLE S, XU J, DERYNCK R. Molecular mecha- nisms of epithelial-mesenchymal transition [ J ]. Nat Rev Mol Cell Biol,2014,15(3) :178.
  • 4YU H, ROHAN T. Role of the insulin-like growth factor family in cancer development and progression [ J ]. J Natl Cancer Inst ,2000,92 ( 18 ) : 1472.
  • 5WEROHA SJ,HALUSKA P. The insulin-like growth factor system in cancer [ J ]. Endocrinol Metab Clin North Am, 2012,41 (2) :335.
  • 6LUKANOVA A, LUNDIN E,TONIOLO P, et al. Circulating levels of insulin-like growth factor-I and risk of ovarian cancer[ J]. Int J Cancer,2002,101 (6) :549.
  • 7BROKAW J, KATSAROS D, WILEY A, et al. IGF-I in epi- thelial ovarian cancer and its role in disease progression [ J ]. Growth Factors,2007,25 ( 5 ) : 346.
  • 8SPENTZOS D, CANNISTRA SA, GRALL FA, et al. IGF ax- is gene expression patterns are prognostic of survival in epi- thelial ovarian cancer [ J ]. Endocr Relat Cancer, 2007,14 (3) :781.
  • 9LIAO GY, WANG MY, OU Y, et al. IGF-l-indueed epithe- lial-mesenehymal transition in MCF-7 eells is mediated by MUC1 [ J ]. Cell Signal ,2014,26 ( 10 ) :2131.
  • 10GRAHAM TR,ZHAU HE,ODERO-MARAH VA,et al. In- sulin-like growth factor-l-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human pros- tate cancer cells[J]. Cancer Res,2008,68(7) :2479.

二级参考文献27

  • 1Lefebvre V, Dumitriu B, Penzo-M6ndez A, et al. Control of cell fate and differentiation by Sry-related high-mobility- group box (Sox) transcription factors [ J ]. Int J Biochem Cell Biol,2007,39(12) :2195.
  • 2Kamachi Y, Uchikawa M, Kondoh H. Pairing SOX off: with partners in the regulation of embryonic development [ J ]. Trends Genet,2000,16 (4) : 182.
  • 3Liu KC,Lin BS,Zhao M, et al. The multiple roles for Sox2 in stem cell maintenance and tumorigenesis [ J ]. Cell Sig- nal,2013,25 (5) :1264.
  • 4Lin F,Lin P, Zhao D, et al. Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis [ J ]. Cell Prolif, 2012,45(3) :207.
  • 5Mukhopadhyay A, Banerjee S, Stafford LJ, et al. Curcumin- induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-media- ted retinoblastora protein phosphorylation [ J ]. Oncogene, 2002,21 (57) :8852.
  • 6Ji J,Zheng PS. Expression of Sox2 in human cervical carci- nogenesis [ J ]. Hum Pathol,2010,41 ( 10 ) : 1438.
  • 7Neumann J, Bahr F,Horst D, et al. SOX2 expression corre- lates with lymph-node metastases and distant spread in right-sided colon cancer[ J]. BMC Cancer,2011 , 11:518.
  • 8Chert YP, Shi L, Zhang L,et al. The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer [J]. J Biol Chem,2008,283(26) :17969.
  • 9Lu Y,Futtner C, Rock JR,et al. Evidence that SOX2 over- expression is oncogenic in the lung[J]. PLoS One,2010,5 (6) :e1 1022.
  • 10Basu M, Roy SS. Wnt/-catenin pathway is regulated by PITX2 homeodomain protein and thus contributes to the proliferation of human ovarian adenocarcinoma cell,SKOV- 3[J]. J Biol Chem 2013 ,288(6) :4355.

共引文献9

同被引文献64

引证文献11

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部